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Rodents with genetic diabetes [1] or rats given streptozotocin
or alloxan [21 have, historically, been the most extensively
studied animal models of diabetes. However, limitations of
these models, including short lifespans, small size, and the
failure to develop nephropathy and retinopathy which precisely
mimic these complications in man, have stimulated the search
for improved model systems. Bloodworth and Engerman [3],
along with Nelson [4], described renal and retinal pathology in
the dog. Furthermore, they demonstrated the efficacy of im-
proved control in preventing the development of retinal pathol-
ogy [4]. However, their model required several years before
clear differences in glomerular basement membrane (GBM)
thickness could be documented between diabetic and control
dogs. This study was carried out to develop a canine model of
diabetic nephropathy in which pathologic changes would be-
come manifest within a shorter time span. Since uninephrec-
tomy in rodents advances the development of diabetic glomeru-
lopathy [5, 6], dogs were uninephrectomized for this study.
Under the chosen conditions, significant renal pathology was
demonstrated after one year of diabetes.
Methods
Purebred male beagles were purchased from one supplier
(Laboratory Research Enterprises, Kalamazoo, Michigan) so
that all animals could be matched for age. Nine-month-old dogs
were made diabetic with an intravenous injection of alloxan (60
mg/kg of body weight), given when the dog's renal arteries were
occluded for 10 mm with a double balloon catheter placed in the
abdominal aorta to protect the animal from acute alloxan
nephrotoxicity (manuscript in preparation). Nondiabetic, age-
matched control dogs received identical balloon occlusion but
without alloxan injection. After approximately 4 weeks, during
which time the induced diabetes was brought under control with
insulin injections, each dog underwent uninephrectomy. The
diabetic animals were then divided into two groups. Dogs of
group 1 received 0.46 U of NPH insulin/kg once each day at 9
A.M. They were maintained at a level of diabetic control so as to
avoid ketoacidosis but not to achieve optimal serum or urinary
glucose levels. Animals of group 2 received significantly better
control by two subcutaneous insulin injections (1.4 U/kg; two
thirds at 9 A.M., one third at 7:30 P.M.) to minimize glucose
spilled into the urine. Blood samples were taken while the dogs
fasted and at 2 hr postprandial for measurement of glucose
levels in the sera. Glucose in urine samples collected for 24 hr
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was measured twice weekly. Glucose concentrations were
measured in urine samples and serum using a hexokinase,
glucose-6-phosphate dehydrogenase procedure (Boehringer
Mannheim).
In control and in both diabetic groups renal tissue was
obtained prior to institution of the study protocol (baseline) and
after 6 and 12 months of diabetes by open renal biopsy with the
intraoperative use of the Vim-Silverman needle. Sodium pento-
barbital (25 mg/kg of body weight) was the anesthetic agent. For
electron microscopy the tissue sample was fixed in 2.5%
glutaraldehyde in 0.17M cacodylate buffer, postfixed in 1%
osmium in cacodylate buffer, and embedded with Polybed 812
(Polysciences, Warrington, Pennsylvania). For light microsco-
py the tissue sample was fixed in Zenker's fixative, embedded
in paraffin, sectioned, and stained with periodic acid Schiff's
(PAS) reagent.
Light microscopy sections were evaluated blindly for mesan-
gial thickening as described previously [7] with a value of 0 for
normal mesangium and l, 2, and 3 used to designate
increasing mesangial volume as apparent with light microscopy.
Electron microscopic morphometry was accomplished with
standard techniques [8]. All samples were evaluated blindly.
Bias in sampling was minimized by selecting the center-most
glomerulus of each block. Two to five glomeruli were studied
from each biopsy. After randomly entering the glomerulus, 10
to 20 electron micrographs (approximately 20,000X) were ob-
tained at regularly-spaced intervals [9]. Fractional volumes of
the total mesangium, and of its cellular and matrix components,
were estimated by placing grids over the electron micrographs
[8, 9]. Fractional volumes of each component were expressed
as a percentage of the total number of points (minimally 2000)
falling on all glomerular tufts [8]. Glomerular basement mem-
brane (GBM) width was measured at each place where grid
lines crossed the GBM. Mean GBM width of at least 100
measurements was calculated using the intercept method of
Gundersen, Jensen, and Østerby [10, 11].
Tissue samples from the baseline, 6-month and 1-year biop-
sies, were evaluated qualitatively and quantitatively. The base-
line measures included tissue samples from animals allocated
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Table 1. Fasting serum and two-hour post-prandial serum glucose levels and urinary glucose excretion in poorly controlled (group I) and well
controlled (group 2) diabetic and in nondiabetic control dogs
Duration of diabetes mellitus
6 Months / Year
Fasting serum glucose, mgldl
Control group
Group 1
Group 2
Two-hourpost-prandial serum glucose
Control group
Group 1
Group 2
Urinapy glucose excretion, g124 hr
Group 1
Group 2
Expressed as mean SD (number of dogs).
b Not significant.
1 109± 4 (8)aP<0.00l
P < 0.001 331 31 (7)
P < 0.001
176 37(11)
102 5 (8)
P < 0.001 328 42 (7)
P <0.001
187 29(11)
52 14 (7)
P < 0.001
17 11(11)
108± 4 (8)
p<0.001 I
376 57 (7) NS5
P<0.001 I
121 29 (11)
102± 3 (8)
P<0.00I I
490±53 (7) P<0.1
P < 0.001 _______J146±66 (11)
78 9.0 (7)
P < 0.001
13 11 (11)
later to control or diabetic groups. In general, urinary glucose
measurements and light and electron microscopy were complet-
ed on each dog. Small differences in the total number of
specimens in each treatment group reflect unsatisfactory speci-
mens that could not be measured.
Results
Serum glucose levels and urinary glucose excretion. Normal
dogs excreted no measurable glucose. Group 1 dogs had very
high serum glucose levels and lost large amounts of glucose in
the urine after becoming diabetic. They had higher serum
values and excreted more glucose in the second 6 months than
during the first (Table 1). Institution of improved control in the
group 2 dogs effectively reduced serum glucose levels and
diminished glucose excretion as compared to group 1 animals.
This improvement was most clearly demonstrable during the
second 6 months when good control with nearly normal serum
levels was uniformly achieved (Table 1).
Light microscopy. Qualitative evaluation of the biopsies after
1 year of diabetes indicated that all animals in group 1 had
abnormal glomeruli based primarily upon mesangial expansion
and increased PAS positive mesangial matrix material (Fig. 1).
In some animals early nodular glomerulosclerosis was evident.
However, the degree of mesangial expansion often varied from
one glomerulus to another within the same biopsy specimen.
Two of seven animals in this group had glomerular arteriolar
hyalinosis lesions. Three of 10 animals in group 2 had normal
biopsies, and two had only minimal changes. However, lesions
in the other five animals were similar to those in group I
animals.
The index of mesangial thickening after 1 year of diabetes
was greater in group I animals (1.5 0.54; mean SD, N = 7),
and in group 2 animals (0.85 0.76, N = 10) than in controls
(0.08 0.10, N = 6; P < 0.001 and P < 0.025, respectively).
The difference between the means of groups 1 and 2 animals
was significant by a one-sided t test (P < 0.05). However,
because of the variability in mesangial thickness in group 2
animals, the marginal statistical significance in comparing
groups I and 2 animals, the lack of demonstrable correlation
between glycosuria and the light microscopic measures, and the
failure to confirm these semiquantitative findings by more
precisely quantitative electron microscopic measurements (see
below), it was judged to be more valid to compare the control
animals with all the diabetic animals (Fig. 2). Clearly, by
examining the glomerular mesangium, differences between dia-
betic and control animals can be discerned by light microscopy
after 1 year of diabetes (Figs. Ia, lb and 2),
Morphometric analysis of glomeruli. Because no statistically
significant differences were measured in comparing groups I
and 2 dogs for any morphometric parameter studied at either 6
months or 1 year (Table 2), the combined results of these two
diabetic groups were compared with controls. After 1 year the
GBM width of the diabetic group exceeded that of the control
group (Table 3). The fractional volume of the total mesangium
in the diabetic dogs surpassed that of the control dogs after I
year. Significant differences were also demonstrable for the
fractional volumes of the cellular mesangium and the matrix
mesangium (Table 3).
Discussion
After 1 year of diabetes in these uninephrectomized and age-
matched male beagle dogs, glomerular pathology was readily
demonstrable by blind reading using light microscopy. Further,
precise electron microscopic morphometry revealed significant
increases in the GBM width and fractional volumes of the
mesangium and its components. Significantly, these parameters
of diabetic nephropathy were measured in needle biopsy speci-
mens from the kidneys. Thus, the opportunity was available to
follow these animals at frequent intervals, taking only small
amounts of tissue. Therefore, the natural history of diabetic
nephropathy in the dog can be monitored, or, in animals
receiving new modalities of diabetic therapy, for example, an
insulin infusion pump, the efficacy of improved control on
halting or reversing these lesions can be evaluated precisely.
Fig. 1. A Light micrograph of a uninephrectomized 21 month-old dog, I
year post uninephrectomy. Note the fine structure of the mesangium.
PAS stain was used. (425x) B Light micrograph of a uninephrecto-
mized and diabetic 21 month-old dog, 1 year post onset of diabetes and
uninephrectomy. The mesangium is substantially expanded (receiving a
grade of 2 to 3f) in contrast with that of the control in A. PAS stain was
used. (425x)
The brief period required for the development of significant
differences between diabetic and nondiabetic dogs was proba-
bly due to several factors. First, the use of relatively inbred,
age-matched dogs may have reduced the interanimal variance
of the parameters studied. Thus, less pathology in glomeruli of
diabetic animals was necessary to demonstrate differences
when compared with nondiabetic dogs. Secondly, it has been
shown that uninephrectomy accelerates diabetic mesangial
changes in rats [5, 6], and this experimental maneuver may have
had a similar effect in the uninephrectomized diabetic dogs.
Comparative studies in intact diabetic dogs are necessary to
validate this thesis. However, there is no evidence that unine-
phrectomy accelerates diabetic GBM thickening (Steffes,
Brown, and Mauer, manuscript in preparation). Thus, the
relatively brief time required to demonstrate increased GBM
thickness in the diabetic beagles was probably due both to the
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first factor and to improved precision in the measurement.
Similarly, in diabetic dogs the detection of increases in the
fractional volume of the total mesangium and both its cellular
and matrix components may have resulted from the application
of more precise quantitative methodologies than have been
applied previously to this animal model.
Prospectively, two levels of control in the diabetic animals
were sought. By 6 months of diabetes significant differences in
serum glucose levels and in urinary glucose excretion were
achieved; by 12 months these differences were even greater. At
12 months mesangial volume and GBM width in both groups 1
and 2 had increased significantly. GBM width tended to be
greater in group 1 as compared to group 2 dogs, but this
difference was not statistically significant. Electron microscop-
ic measurements of the mesangium were nearly identical be-
tween groups 1 and 2 animals. However, the light microscopic
index of mesangial thickening was greater in group 1 compared
to group 2 dogs. This discrepancy could have been due to
variability between glomeruli that may be more readily detected
with light microscopic sections wherein many glomeruli may be
evaluated. Continued monitoring of these animals may yet
reveal disparities between these groups under two different
levels of diabetic control. Nonetheless, the development of
lesions characteristic of diabetic glomerulopathy in these dogs
with experimental diabetes confirms previous observations
implicating the dysmetabolism of diabetes as being responsible
for its secondary complications.
This study demonstrated that the dog is a practical and
valuable model for studies of the pathogenesis, treatment, and
prevention of diabetic nephropathy. The size of the animal
makes it possible to evaluate new technologies, such as im-
plantable insulin pumps, which are potentially applicable to
man. This experimental model of diabetes also permits bio-
Diabetic nephropathy in the uninephrectomized dog 723
Controls Diabetics
2.5
2.0 Do
.
U.
•1
DID
UD
0
S
0.5
Fig. 2. Light microsocpic index of the volume of mesangium in
uninephrectomized and uninephrectomized-diabetic dogs. Of the dia-
betic animals, the closed squares designate dogs receiving poorer
control (group 1); the open squares, dogs with good control (group 2);
the closed circles, control dogs; I 5 SEM. Significance given is
between the controls and all diabetic animals grouped together.
-.
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Table 2. Glomerular basement membrane (GBM) width and fractional
volumes of the total mesangium and of its cellular and matrix
components (expressed as percentages of the glomerular tuft) in
groups I and 2 diabetic dogsa
Groups
Duration of diabetes mellitus
6 months 1 year
GBM width, nm
1 189 18 (7)b 264 41 (7)
2 196 23 (11) 243 31
Total mesangium, %
(11)
1 20.3 6.1 (7) 23.4 7.1 (7)
2 16.6 4.8 (11) 23.7 6.1
Cellular mesangium, %
(11)
1 10.9 5.4 (7) 9.5 3.8 (7)
2 7.6 3.2 (Il) 10.7 3.1
Matrix mesangium, %
(11)
1 9.3 3.0 (7) 13.9 3.5 (7)
2 9.0 2.8 (11) 13.0 3.3 (11)
a Biopsies were taken after 6 months and 1 year of diabetes;
comparison between values from groups I and 2 is significant.
b Expressed as mean SD (number of dogs).
no
Table 3. Glomerular basement membrane (GBM) width and fractional
volumes of the total mesangium and of its cellular and matrix
components (expressed as percentages of the glomerular tuft) in
control and diabetica dogs
Group
Biopsies taken
Baselineb 6 months 1 year
GBM width, nm
Control 160 20 (1 l)c 189 23 (8)
NSd
207 12 (8)
P < 0.001
Diabetic 194 21 (18)
Total mesangium, %
251 36 (18)
Control 12.8 2.7 (11) 17.0 4.0 (8)
NS
16.5 5.1 (8)
P<0.01
Diabetic 18.0 5.5 (18)
Cellular mesangium, %
23.6 6.3 (18)
Control 6.1 1.7 (11) 7.3 1.8 (8)
NS
7.3 2.8 (8)
P<0.05
Diabetic 8.9 4.4 (18)
Matrix mesangium, %
10.2 3.3 (18)
Control 6.7 1.4 (11) 9.7 3.0 (8)
NS
9.2 2.8 (8)
P < 0.005
Diabetic 9.1 2.8 (18) 13.4 3.3 (18)
a At 6 months and 1 year of diabetes, the groups 1 and 2 diabetic dogs
demonstrated no differences in the GBM and mesangial measures. The
results presented encompass values from all diabetic animals.
b Baseline values represent sampling of all groups prior to diabetes.
Expressed as mean SD (number of dogs).
d Not significant.
chemical, hormonal, and physiologic studies which would be
difficult or impossible to perform in smaller animals.
Summary. Carefully age-matched, purebred male beagle dogs
that underwent uninephrectomy one month after they were
made diabetic with alloxan were used to establish a model of
rapidly developing diabetic nephropathy in a large animal. The
diabetic animals, all requiring insulin, were divided into two
groups: one group with control by insulin injections permitting
elevated fasting and postprandial serum glucose values and
substantial glycosuria; the other with better control and with
near-normal serum glucose levels and less glycosuria. By 1 year
of diabetes both diabetic groups had renal lesions different from
the uninephrectomized control animals but differing only slight-
ly from one another. With light microscopy, diabetic dogs had
increased mesangial thickening. With electron microscopic
morphometry, glomeruli of diabetic subjects demonstrated in-
creased fractional volumes of the total mesangium and of its
cellular and matrix components and increased width of the
GBM. These quantitative measures of diabetic nephropathy in
the dog within 1 year of onset of the disease describe a model
potentially useful in evaluating the efficacy of improved diabetic
control in preventing or ameliorating diabetic nephropathy.
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